Study to Collect Bio-Specimens from Adults with Pancreatic Cysts or High Risk for Pancreatic Cancer

What this Trial Is About

Researchers are studying two groups of patients who are at high risk for developing pancreatic cancer. One group includes patients diagnosed with pancreatic cysts who are undergoing endoscopic ultrasound or surgery. The other group includes patients considered high risk due to family history or known genetic mutations. The purpose is to collect and analyze bio-specimens to better understand early detection of pancreatic cancer. The study collects bio-specimens such as pancreatic cyst fluid and blood from patients with pancreatic cysts during their clinical procedures. For high-risk individuals without cysts, blood samples are collected. All collections follow a standard operating protocol. This is an observational study, so no treatments are given the focus is on gathering samples and monitoring over time. Participants will provide bio-specimens as part of their routine care or scheduled visits. Researchers will evaluate these samples and observe participants over 5 to 10 years to track the development of pancreatic cancer. The study involves ongoing data collection and long-term monitoring to help identify early signs of the disease. The total participation duration varies depending on individual follow-up.

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer